Pleural mesothelioma, specifically, is the most common type of mesothelioma, and it affects the mesothelial lining around the lungs. Why Are the Symptoms of Pleural Mesothelioma So Hard to Spot?

The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034). The launch of innovative therapies by companies such as AstraZeneca, Polaris ...

“In (pleural) mesothelioma, even in (the) early stages, it’s not completely cured with just one modality; the results are not good with (just) one (treatment).” Traditional treatment for patients with ...

For example, pleural mesothelioma patients with BAP1 germline mutations who receive platinum-based chemotherapy live significantly longer, 7.9 years compared to 2.4 years for those without these ...

Malignant pleural mesothelioma continues to be a challenge. The diagnosis and treatment of patients with malignant pleural mesothelioma requires a multidisciplinary approach. The diagnosis is best ...

Mesothelioma is a rare but almost always fatal form of cancer linked to asbestos exposure. It is predominantly detected among ...

Pleural mesothelioma – a type of cancer caused by asbestos in the lining of the lungs – is the most common type of this disease. Roughly 70% of the total number of mesothelioma cases involve ...

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study identified the oncoprotein YB-1 as an ...

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

Because pleural mesothelioma is interspersed around the lung, it cannot be simply removed through surgery the way lung cancer is, Raj elaborated, which results in different treatments between the two.

After a long period of neglect, malignant pleural mesothelioma has received the necessary attention by the oncological community over the past decade. Major molecular drivers of the disease have ...